Chemical Name: (S)-4,8,11-Triethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate
Synonym: Irinotecan 11-Ethyl Impurity (USP)
Smiles: O[C@@](C(OC1)=O)(CC)C2=C1C(N3C(C4=NC5=CC(CC)=C(OC(N6CCC(N7CCCCC7)CC6)=O)C=C5C(CC)=C4C3)=C2)=O
Inchi: InChI=1S/C31H34N4O6.ClH.H2O/c1-2-31(39)24-16-26-27-20(17-35(26)28(36)23(24)18-40-29(31)37)14-19-15-22(6-7-25(19)32-27)41-30(38)34-12-8-21(9-13-34)33-10-4-3-5-11-33;;/h6-7,14-16,21,39H,2-5,8-13,17-18H2,1H3;1H;1H2/t31-;;/m0../s1/i;;1-13
RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67
Method development, validation and forced degradation studies of Irinotecan in bulk and pharmaceutical dosage form
By Swathi, Koduru; Farooqui, Tahmeena; Muntaha, Sidra Tul; Ayesha, Syeda Amtul; Shama, Syeda; Siddiqui, Sarah Imam
From World Journal of Pharmacy and Pharmaceutical Sciences (2018), 7(8), 996-1009